Identification of biological markers of cancer and development of new diagnostic tools. Development of new targeted therapies and innovative drugs against cancer.
Principal Investigators
-
Katherine Borden
Structure and Function of the Cell Nucleus
-
Delphine Bouilly
Design and Application of Electronic Nanobiosensors
-
Michel Bouvier
Molecular Pharmacology
-
Sébastien Carréno
Cellular Mechanisms of Morphogenesis during Mitosis and Cell Motility
-
Louis Gaboury
Histology and Molecular Pathology
-
Etienne Gagnon
Cancer Immunobiology
-
Trang Hoang
Hematopoiesis and Leukemia
-
Julie Lessard
Chromatin Structure and Stem Cell Biology
-
Sylvie Mader
Molecular Targeting in Breast Cancer Treatment
-
François Major
RNA Engineering
-
Anne Marinier
Drug Discovery
-
Sylvain Meloche
Signalling and Cell Growth
-
Philippe P. Roux
Cell Signaling and Proteomics
-
Claude Perreault
Immunobiology
-
Guy Sauvageau
Molecular Genetics of Stem Cells
-
Marc Therrien
Intracellular Signalling
-
Pierre Thibault
Proteomics and Mass Spectrometry
-
Vincent Quoc-Huy Trinh
Digital Histology and Advanced Pathology
-
Brian Wilhelm
High-Throughput Genomics
Publications
-
March 22, 2024 SF3B1 mutations provide genetic vulnerability to copper ionophores in human acute myeloid leukemia.
Moison C, Gracias D, Schmitt J, Girard S, Spinella JF, Fortier S, Boivin I, Mendoza-Sanchez R, Thavonekham B, MacRae T, Mayotte N, Bonneil E, Wittman M, Carmichael J, Ruel R, Thibault P, Hébert J, Marinier A, Sauvageau G
Sci Adv 2024-03-22 ;10( 12 ):eadl4018 - See all publications